Tower Research Capital »

Apimeds Pharmaceuticals Us I shares owned by Tower Research Capital

Quarter-by-quarter ownership of Apimeds Pharmaceuticals Us I (APUS) shares owned by Tower Research Capital from 13F filings

Historical chart of Tower Research Capital investment in Apimeds Pharmaceuticals Us I

Tip: Access up to 7 years of quarterly data

All positions including Apimeds Pharmaceuticals Us I held by Tower Research Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apimeds Pharmaceuticals Us I by Tower Research Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $16 10 1.60
2025-06-30 $5.5k 3.2k 1.76

More positions owned by Tower Research Capital

Apple (AAPL)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Spdr Series Trust State Street Spd (SJNK)
Invesco Actively Managed Exc Ultra Shrt Dur (GSY)
Ishares Tr Russell 2000 Etf (IWM)
Advanced Micro Devices (AMD)
Wisdomtree Tr Floatng Rat Trea (USFR)
JPMorgan Chase & Co. (JPM)

View all positions for Tower Research Capital

Top funds holding Apimeds Pharmaceuticals Us I

Hemenway Trust Company
Vanguard Group
Geode Capital Management
Jane Street
UBS Group
Tower Research Capital

View all funds holding Apimeds Pharmaceuticals Us I